Elixem LLC is developing an innovative AI-powered solution that integrates Health IoT, DNA Methylation Analysis, and Digital Twin Technology. By leveraging real-time patient monitoring and biomarker analysis, this system enables early disease detection, personalized treatment, and continuous health assessments. Addressing challenges such as late-stage diagnoses, fragmented data, and the lack of AI-driven insights, this approach leads to better health outcomes and reduced treatment costs.

Developed with the expertise of sector specialists and pioneers in the field, this data-driven model uses real-time biosensing and AI to identify early signs of diseases like cancer and cardiovascular conditions. Digital Twin technology creates a dynamic virtual representation of the patient, enabling personalized interventions and more efficient treatment. By reducing preventable hospitalizations and improving healthcare resource allocation, Elixem LLC’s solution is transforming healthcare into a proactive, patient-centric model, enhancing patient survival rates and lowering healthcare costs.